Full Breakdown
Ebola Outbreak in Eastern DR Congo Shows Signs of Slowdown Amid Ongoing Risks
By Drooid · · How we work
Core Developments: Declining Cases and Expanded Surveillance
Daily reports of new Ebola cases have fallen from roughly 120 at the height of the outbreak in mid-August to about 80 in recent weeks. Ten of the 62 affected health zones have recorded no new cases for more than 22 days, indicating localized containment. Nevertheless, the virus continues to spread, now reaching seven provinces, with a sharp rise in North Kivu where 555 of the 1,269 confirmed cases since the outbreak began were reported in the past 21 days.
Background & Context
The epidemic was officially declared on May 15. It is driven by the rare Bundibugyo strain of Zaire ebolavirus, for which no approved vaccine or specific treatment exists, although clinical trials are under way. The outbreak follows the 2014-16 West-African epidemic, the deadliest on record.
Data & Statistics
- Confirmed cases: more than 7,000 across seven provinces as of September 11 (World Health Organisation (WHO)).
- Total infections reported by other sources: 7,258.
- Death toll: at least 3,510 and more than 3,510.
- Vaccinations: over 3,000 healthcare and frontline workers have received Merck’s Ervebo vaccine, though its effectiveness against the Bundibugyo strain remains unproven.
Official Statements & Responses
- WHO Director-General Tedros Adhanom Ghebreyesus said transmission is declining in the most affected parts of Ituri province and described the situation as showing “encouraging signs,” while warning that the outbreak remains “far from over.”
- UN special Ebola coordinator Julien Harneis acknowledged “areas of progress” but emphasized that the epidemic is still “deadly and massive.”
- Democratic Republic of Congo (DRC) health minister Samuel Roger Kamba suggested the outbreak has passed its peak.
Criticism & Opposition
UN officials, including Harneis and Le Polain, argue that declaring a peak prematurely could undermine ongoing response efforts, especially given continued spread in conflict-affected North Kivu and the reliance on high-mobility populations for transmission.
Conflicting Reports & Gaps
- Peak Assessment: The health minister’s claim that the outbreak has passed its peak contrasts with UN and WHO statements that it is too early to make that determination.
- Case Numbers: WHO reports “more than 7,000” cases, while Independent sources cite a total of 7,258 infections, reflecting a modest discrepancy in counting methods.
- Vaccine Efficacy: Over 3,000 workers have been vaccinated with Ervebo, yet the vaccine’s effectiveness against the current Bundibugyo strain remains unverified, and observational studies are only beginning.
Verbatim Quotes
- “We have many, many months ahead of us,” — Van Kerkhove, WHO's acting director of epidemic and pandemic threat management
What’s Next
An observational study to evaluate Ervebo’s effectiveness among frontline workers is slated to begin shortly. A mid-to-late-stage trial, led by Congo’s National Institute of Biomedical Research with international partners, is expected to start in the coming weeks and will test Ervebo alongside candidates from Moderna and the University of Oxford. Additionally, health officials are employing anonymised mobile-phone data to anticipate population movements and target future vaccination and surveillance efforts.
